| Morphine Sulphate 60 mg/ml Solution for Injection PA0073/020/008 |
Morphine sulfate |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| MST Continus 10 mg Prolonged-release tablets PA1688/004/002 |
Morphine sulfate |
Mundipharma Pharmaceuticals Limited |
Marketed |
| MST Continus 100mg Prolonged-release tablets PA1688/004/006 |
Morphine sulfate |
Mundipharma Pharmaceuticals Limited |
Marketed |
| MST Continus 15 mg Prolonged-release tablets PA1688/004/003 |
Morphine sulfate |
Mundipharma Pharmaceuticals Limited |
Marketed |
| MST Continus 30 mg Prolonged-release tablets PA1688/004/004 |
Morphine sulfate |
Mundipharma Pharmaceuticals Limited |
Marketed |
| MST Continus 5 mg prolonged-release tablets PA1688/004/001 |
Morphine sulfate |
Mundipharma Pharmaceuticals Limited |
Marketed |
| Mybufen 200 mg Film-coated Tablets PA1436/039/001 |
Ibuprofen |
Bluefish Pharmaceuticals AB |
Marketed |
| Mybufen Max 400 mg Film-coated Tablets PA1436/039/002 |
Ibuprofen |
Bluefish Pharmaceuticals AB |
Marketed |
| Mybufen Max Rapid 400 mg soft capsules PA1436/046/001 |
Ibuprofen |
Bluefish Pharmaceuticals AB |
Not marketed |
| Mycamine 100 mg powder for solution for infusion EU/1/08/448/002 |
Micafungin sodium |
Sandoz Pharmaceuticals d.d. |
— |
| Mycamine 50 mg powder for concentrate for solution for infusion EU/1/08/448/001 |
Micafungin sodium |
Sandoz Pharmaceuticals d.d. |
— |
| Naloxone Hydrochloride 400 micrograms/ml Solution for Injection or Infusion PA0073/111/002 |
NALOXONE HYDROCHLORIDE |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| Naproxen 250 mg Gastro-resistant Tablets PA22871/007/001 |
Naproxen |
Azure Pharmaceuticals Ltd. |
Marketed |
| Naproxen 500 mg Gastro-resistant Tablets PA22871/007/003 |
Naproxen |
Azure Pharmaceuticals Ltd. |
Marketed |
| Naratriptan 2.5 mg film-coated tablet PA22865/008/001 |
Naratriptan hydrochloride |
Renata Pharmaceuticals (Ireland) Limited |
Not marketed |
| Nasonex 50 micrograms/actuation Nasal Spray, Suspension PPA23080/001/001 |
Mometasone furoate |
Merit Pharmaceuticals Limited |
— |
| Natpar 100 micrograms/dose powder and solvent for solution for injection EU/1/15/1078/004 |
Parathyroid hormone (rdna) |
Shire Pharmaceuticals Ireland Limited |
— |
| Natpar 25 micrograms/dose powder and solvent for solution for injection EU/1/15/1078/001 |
Parathyroid hormone (rdna) |
Shire Pharmaceuticals Ireland Limited |
— |
| Natpar 50 micrograms/dose powder and solvent for solution for injection EU/1/15/1078/002 |
Parathyroid hormone (rdna) |
Shire Pharmaceuticals Ireland Limited |
— |
| Natpar 75 micrograms/dose powder and solvent for solution for injection EU/1/15/1078/003 |
Parathyroid hormone (rdna) |
Shire Pharmaceuticals Ireland Limited |
— |
| Negaban 1 g powder for solution for injection/infusion PA23460/002/001 |
Temocillin disodium |
Eumedica Pharmaceuticals GmbH |
Not marketed |
| Negaban 2 g powder for solution for injection/infusion PA23460/002/002 |
Temocillin sodium |
Eumedica Pharmaceuticals GmbH |
Not marketed |
| Neo-Cytamen 1000 micrograms/ml Solution for Injection PA1638/004/001 |
Hydroxocobalamin |
RPH Pharmaceuticals AB |
Marketed |
| Nexium 20 mg gastro-resistant tablets PPA23080/003/001 |
Esomeprazole |
Merit Pharmaceuticals Limited |
— |
| Nexium 40 mg gastro-resistant tablets PPA23080/003/002 |
Esomeprazole |
Merit Pharmaceuticals Limited |
— |
| Niapelf 100 mg prolonged-release suspension for injection EU/1/24/1795/004 |
Paliperidone |
Neuraxpharm Pharmaceuticals S.L. |
— |
| Niapelf 150 mg and Niapelf 100 mg prolonged-release suspension for injection EU/1/24/1795/006 |
Paliperidone |
Neuraxpharm Pharmaceuticals S.L. |
— |
| Niapelf 150 mg prolonged-release suspension for injection EU/1/24/1795/005 |
Paliperidone |
Neuraxpharm Pharmaceuticals S.L. |
— |
| Niapelf 25 mg prolonged-release suspension for injection EU/1/24/1795/001 |
Paliperidone |
Neuraxpharm Pharmaceuticals S.L. |
— |
| Niapelf 50 mg prolonged-release suspension for injection EU/1/24/1795/002 |
Paliperidone |
Neuraxpharm Pharmaceuticals S.L. |
— |
| Niapelf 75 mg prolonged-release suspension for injection EU/1/24/1795/003 |
Paliperidone |
Neuraxpharm Pharmaceuticals S.L. |
— |
| Nithiodote Solution for Injection PA22874/003/001 |
SODIUM NITRITE, Sodium thiosulfate |
Hope Pharmaceuticals Ltd |
Not marketed |
| Nitrofurantoin 100 mg hard capsules PA22871/024/002 |
Nitrofurantoin |
Azure Pharmaceuticals Ltd. |
Marketed |
| Nitrofurantoin 100 mg hard capsules PA1567/004/002 |
Nitrofurantoin, macrocrystalline |
Activase Pharmaceuticals Limited |
Not marketed |
| Nitrofurantoin 50 mg hard capsules PA22871/024/001 |
Nitrofurantoin |
Azure Pharmaceuticals Ltd. |
Marketed |
| Nitrofurantoin 50 mg hard capsules PA1567/004/001 |
Nitrofurantoin, macrocrystalline |
Activase Pharmaceuticals Limited |
Not marketed |
| Nityr 10 mg tablet EU/1/18/1290/001 |
Nitisinone |
Cycle Pharmaceuticals (Europe) Ltd |
— |
| Olanzapine Mylan 2.5 mg film-coated tablets EU/1/08/475/1-6 |
Olanzapine |
Mylan Pharmaceuticals Limited |
— |
| Olanzapine Mylan 10 mg film-coated tablets EU/1/08/475/18-24 |
Olanzapine |
Mylan Pharmaceuticals Limited |
— |
| Olanzapine Mylan 15 mg film-coated tablets EU/1/08/475/25-29 |
Olanzapine |
Mylan Pharmaceuticals Limited |
— |
| Olanzapine Mylan 20 mg film-coated tablets EU/1/08/475/30-34 |
Olanzapine |
Mylan Pharmaceuticals Limited |
— |
| Olanzapine Mylan 5 mg film-coated tablets EU/1/08/475/7-12 |
Olanzapine |
Mylan Pharmaceuticals Limited |
— |
| Olanzapine Mylan 7 mg film-coated tablets EU/1/08/475/13-17 |
Olanzapine |
Mylan Pharmaceuticals Limited |
— |
| Olazax 10 mg tablets EU/1/09/597/003 |
Olanzapine |
Glenmark Pharmaceuticals s.r.o. |
— |
| Olazax 15 mg tablets EU/1/09/597/004 |
Olanzapine |
Glenmark Pharmaceuticals s.r.o. |
— |
| Olazax 20 mg tablets EU/1/09/597/005 |
Olanzapine |
Glenmark Pharmaceuticals s.r.o. |
— |
| Olazax 5 mg tablets EU/1/09/597/001 |
Olanzapine |
Glenmark Pharmaceuticals s.r.o. |
— |
| Olazax 7.5 mg tablets EU/1/09/597/002 |
Olanzapine |
Glenmark Pharmaceuticals s.r.o. |
— |
| Olazax Disperzi EU/1/09/592/002 |
Olanzapine |
Glenmark Pharmaceuticals s.r.o. |
— |
| Olazax Disperzi 10 mg orodispersible tablets EU/1/09/592/003 |
Olanzapine |
Glenmark Pharmaceuticals s.r.o. |
— |